<DOC>
	<DOCNO>NCT00441259</DOCNO>
	<brief_summary>This randomise , double-blind study conduct 96 subject multiple site India . Subjects enrol age group randomise either ChimeriVax™-JE ( JE-CV ) JE Mouse Brain Derived Vaccine ( JE-MBDV ) . Study consist screen period , treatment period 2 year follow-up period . Primary safety endpoint adverse event ( AE ) rate 28 day completion vaccination course . The primary efficacy endpoint rate seroconversion 28 day complete vaccination .</brief_summary>
	<brief_title>Safety Efficacy Study ChimeriVax™-JE JE Inactivated Mouse Brain Vaccine Children Descending Age</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All aspect Protocol explain write informed consent obtain subject 's parent guardian assent child ≥ 8 year age . Aged ≥ 9 month &lt; 10 year In good general health , without significant medical history , physical examination finding , clinically significant abnormal laboratory result Subject available study duration study duration , include plan followup visit . A history vaccination , infection , JE flaviviruses ( e.g . Kyanasur Forest Disease , West Nile virus , dengue fever ) . Previous JE vaccination determine history ( interview subject 's parent guardian ) inspect child 's official vaccination record . Demonstration parasitemia malaria blood smear Screening . History residence travel JEendemic region India elsewhere Asia ( period 4 week ) . hypersensitivity thimerosal gelatin Have receive transfusion blood , blood product serum globulin precede 6 month , Have immunodeficiency neurological disorder , take drug suppress immune system , Have history severe reaction vaccine , Have chronic condition require medication , Intend travel area study period , Have spend least 4 week JEendemic region , Plan receive vaccination within doubleblind treatment period , receive vaccination month precede Screening , Exhibit sign secondary tertiary malnutrition , Are seropositive human immunodeficiency virus ( HIV ) , Hepatitis B C , Have malaria infection , fever within 3 day vaccination . Those acute fever , previously schedule vaccination , may reschedule . Consideration routine immunisation schedule make ensured routine vaccination due either give entry trial , afterwards delay trial .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Japanese Encephalitis</keyword>
</DOC>